Project
PALLAS (IBCSG 52-16)
Ongoing - recruitment closed · 2016 until 2099
Huober Jens, Munz Jeannine, Müller Fiona
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment closed
Start Date
2016
End Date
2099
Financing
Industry
Labels
gynecological tumors
Brief description/objective
A randomized phase III trial of Palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for hormone receptor positive (HR+) / human epidermal growth factor receptor 2 (HER2)-negative early breast cancer. PALLAS: PALbociclib CoLlaborative Adjuvant Study.